1 – 10 of 238
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2026
-
Mark
Associations of modifiable and non-modifiable risk factors with longitudinal white matter hyperintensities, amyloid-β and tau - a prospective cohort study
(2026) In The journal of prevention of Alzheimer's disease
- Contribution to journal › Article
-
Mark
Integration of plasma eMTBR-tau243 and p-tau217 in the diagnosis and stratification of Alzheimer's disease : a prospective cohort study
- Contribution to journal › Article
- 2025
-
Mark
A comparison of p-tau assays for the specificity to detect tau changes in Alzheimer's disease
- Contribution to journal › Article
-
Mark
Tau, atrophy, and domain-specific cognitive impairment in typical Alzheimer's disease
- Contribution to journal › Article
-
Mark
Prediction of amyloid and tau brain deposition and cognitive decline in people with Down syndrome using plasma biomarkers : a longitudinal cohort study
- Contribution to journal › Article
-
Mark
Increased plasma DOPA decarboxylase levels in Lewy body disorders are driven by dopaminergic treatment
- Contribution to journal › Article
-
Mark
Plasma MTBR-tau243 biomarker identifies tau tangle pathology in Alzheimer's disease
- Contribution to journal › Article
-
Mark
Machine learning prediction of tau-PET in Alzheimer's disease using plasma, MRI, and clinical data
- Contribution to journal › Article
-
Mark
Benchmarking Alzheimer’s disease prediction : personalised risk assessment using polygenic risk scores across various methodologies and genome-wide studies
- Contribution to journal › Article
-
Mark
Soluble cerebral Aβ protofibrils link Aβ plaque pathology to changes in CSF Aβ42/Aβ40 ratios, neurofilament light and tau in Alzheimer’s disease model mice
- Contribution to journal › Article
